|
|
Research progress on the mechanism of traditional Chinese medicine treatment of depression complicated with coronary heart disease based on cell pyroptosis |
LI Lanshi1 WANG Ying2 |
1.Graduate School, Liaoning University of Traditional Chinese Medicine, Liaoning Province, Shenyang 110032, China;
2.Clinical Teaching and Research Department of Acupuncture, Liaoning University of Traditional Chinese Medicine, Liaoning Province, Shenyang 110032, China |
|
|
Abstract Depression and coronary heart disease are both chronic inflammatory diseases, the harms of inflammatory responses in the occurrence and development of the two diseases have been recognized. It was found that the rates of incidence and mortality of coronary heart in depression patients were increasing day by day. Recently studies had found that depression caused a variety of individual brain cells pyroptosis especially the microglia pyroptosis, it could promote the highly pro-inflammatory programmed cell death mode. And the cascaded inflammation responces caused by pyroptosis in the brain are an important molecular mechanism that may induces vascular endothelial injurying, atherosclerosis, and ultimately coronary heart disease for depressed patients. At the same time, a large number of cells, animals, and clinical experiments had proved that a variety of traditional Chinese medicine could treat depression combined with coronary heart disease by regulating the expression of various proteins about pyroptosis, and the curative effect was significant. This paper intends to sort out the specific mechanism of traditional Chinese medicine action from the perspective of cell pyroptosis, hoping to provide new ideas and possibilities for clinical prevention and treatment of depression complicated with coronary heart disease.
|
|
|
|
|
[1] 中国心血管健康与疾病报告2019[J].心肺血管病杂志,2020,39(10):1157-1162.
[2] O’Neil A,Fisher AJ,Kibbey KJ,et al. Depression is a risk factor for incident coronary heart disease in women:An 18-year longitudinal study [J]. J Affect Disord,2016,196:117-124.
[3] Zhaolin Z,Guohua L,Shiyuan W,et al. Role of pyroptosis in cardiovascular disease [J]. Cell Prolif,2019,52(1):117761.
[4] Xu YJ,Zheng L,Hu YW,et al. Pyroptosis and its relationship to atherosclerosis [J]. Clin Chim Acta,2018,476:28-37.
[5] 石哲玮,秦铖璠,钱彩珍,等.NF-κB蛋白在柯萨奇病毒B3诱导的病毒性心肌炎小鼠心肌细胞焦亡过程中的调控作用[J].中国病理生理杂志,2021,37(2):240-245.
[6] Kim BW,Koppula S,Kumar H,et al. Corrigendum to “α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson’s disease” [J]. Neuropharmacolo,2017,116:444-445.
[7] Tang X,Huang G,Zhang T,et al. Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis:inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways [J]. Biosci Biotechnol Biochem,2020,84(9):1903-1912.
[8] Zhang YX,Zhang XT,Li HJ,et al. Antidepressant-like effects of helicid on a chronic unpredictable mild stress-induced depression rat model:Inhibiting the IKK/IκBα/NF-κB pathway through NCALD to reduce inflammation [J]. Int Immunopharmacol,2021,93:107165.
[9] Hu J,Zhou J,Wu J,et al. Loganin ameliorates cartilage degeneration and osteoarthritis development in an osteoarthritis mouse model through inhibition of NF-κB activity and pyroptosis in chondrocytes [J]. Ethnopharmacol,2020,247:112261.
[10] Li Y,Liang W,Guo C,et al. Renshen Shouwu extract enhances neurogenesis and angiogenesis via inhibition of TLR4/NF-κB/NLRP3 signaling pathway following ischemic stroke in rats [J]. J Ethnopharmacol,2020,253:112616.
[11] Choi YH,Myung NY. The Anti-inflammatory Mechanism of the Peel of Zanthoxylum piperitum D.C. is by Suppressing NF-κB/Caspase-1 Activation in LPS-Induced RAW264.7 Cells [J]. Kor J of Pl Res,2019,32(6):669-676.
[12] Yao M,Fan X,Yuan B,et al. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell [J]. BMC Complement Altern Med,2019,19(1):216.
[13] Kim SK,Choe JY,Park KY. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7 [J]. Biochem Biophys Res Commun,2019,517(2):338-345.
[14] Leu WJ,Chen JC,Guh JH. Extract From Plectranthus amboinicus Inhibit Maturation and Release of Interleukin 1β Through Inhibition of NF-κB Nuclear Translocation and NLRP3 Inflammasome Activation [J]. Front Pharmacol,2019,10:573.
[15] Chen Y,Hu Z,Li R,et al. The Effects of Carbenoxolone against Experimental Autoimmune Encephalomyelitis in a Mouse Model [J]. Neuroimmunomodulation,2020,27(1):19-27.
[16] Li X,Liu Y,Cao A,et al. Crocin Improves Endothelial Mitochondrial Dysfunction via GPx1/ROS/KCa3.1 Signal Axis in Diabetes [J]. Front Cell Dev Biol,2021,9:651434.
[17] 黄茸茸,陆松侠,许燕,等.白果内酯对Aβ (25-35)诱导HT22细胞损伤及NLRP-1炎症小体激活的影响[J].中成药,2020,42(9):2317-2323.
[18] Tang YS,Zhao YH,Zhong Y,et al. Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway [J]. Inflamm Res,2019,68(9):727-738.
[19] Yu M,Man YL,Chen MH,et al. Hirsutella sinensis inhibits NLRP3 inflammasome activation to block aristolochic acid-induced renal tubular epithelial cell transdifferentiation [J]. Hum Cell,2020,33(1):79-87.
[20] Li Q,Zhang Z,Li H,et al. Lycium barbarum polysaccharides protects H9c2 cells from hypoxia-induced injury by down-regulation of miR-122 [J]. Biomed Pharmacother,2019,9:1427.
[21] Wu X,Zhang H,Qi W,et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis [J]. Cell Death Dis,2018,9(2):171.
[22] Lee Y,Kang J,Yun M,et al. Curcumin inhibits poly(dA:dT)-induced IL-18 secretion by inhibiting the ASC oligomerization in human keratinocytes [J]. Mol & Cell Toxic,2019,15(4):399-406.
[23] Wang Z,Xu G,Gao Y,et al. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome [J]. Acta Pharm Sin B,2019,9(4):734-744.
[24] 李学勤,郝长锁,付迎新.穿心莲内酯对LPS吸入性肺炎新生大鼠NLRP3、ASC及caspase-1表达的影响[J].重庆医学,2020,49(13):2071-2076,2081.
[25] Lee HW,Lee CG,Rhee DK,et al. Sinigrin inhibits production of inflammatory mediators by suppressing NF-κB/MAPK pathways or NLRP3 inflammasome activation in macrophages [J]. Int Immunopharmacol,2017,45:163-173.
[26] Wu J,Luo Y,Jiang Q,et al. Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1 [J]. Pharmacol Res,2019,147:104348.
[27] Wang L,Yu Z,Wei C,et al. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation [J]. Oncotarget,2017,8(20):32937-32945.
[28] Rui W,Li S,Xiao H,et al. Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/Caspase-1/GSDMD Pathway in MPTP-Induced Mice Model of Parkinson’s Disease [J]. Int J Neuropsychopharmacol,2020,23(11):762-773.
[29] 张林玲,石伟林.基于NLRP3/caspase-1通路研究黄芩苷对大鼠动脉硬化模型的保护作用[J].热带医学杂志,2020,20(11):1394,1405-1409.
[30] Wang J,Guo M,Ma R,et al. Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1 [J]. Peer J,2020,8:e9042.
[31] Udjus C,Cero FT,Halvorsen B,et al. Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension [J]. Am J Physiol Lung Cell Mol Physiol,2019,316(6):999-1012.
[32] Goh G,Ahn M,Zhu F,et al. Complementary regulation of caspase-1 and IL-1β reveals additional mechanisms of dampened inflammation in bats [J]. Proc Natl Acad Sci USA,2020,117(46):28939-28949.
[33] Li J,Li X,Wang X,et al. Sesquiterpenoids and Their Anti-Inflammatory Activity:Evaluation of Ainsliaea yunnanensis [J]. Molecules,2019,24(9):1701.
[34] Xing SS,Yang J,Li WJ,et al. Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis [J]. Inflammation,2020,43(2):433-440.
[35] Shi J,Gao W,Shao F. Pyroptosis:Gasdermin-Mediated Programmed Necrotic Cell Death [J]. Trends Biochem Sci,2017,42(4):245-254.
[36] 辛文妤,韦珍妮,张颖,等.雷公藤红素对巨噬细胞焦亡的影响[J].中草药,2018,49(5):1087-1091.
[37] He C,Yang J,Jiang X,et al. Kaempferol alleviates LPS-ATP mediated inflammatory injury in splenic lymphocytes via regulation of the pyroptosis pathway in mice [J]. Immunopharmacol Immunotoxicol,2019,41(5):538-548. |
|
|
|